文献速递肥胖与代谢综合征

减重手术后细胞因子、趋化因子及受体变化与代谢改善相关

Cytokine, Chemokine, and Cytokine Receptor Changes Are Associated With Metabolic Improvements After Bariatric Surgery.
PubMed 文献 · J Clin Endocrinol Metab · 2019-01-01

该横断面研究对比37例肥胖患者与37例瘦对照者的76种循环细胞因子、趋化因子及分泌型受体,并追踪25例肥胖患者减重手术后的变化。研究发现肥胖者13种细胞因子升高、4种降低,术后sVEGFR2下降、CXCL12上升,且术前sIL-1R2和sIL-6R较高者术后减重更多。

要点

  • 肥胖者存在多种细胞因子、趋化因子及受体的差异表达。
  • 减重手术可使部分细胞因子谱向瘦对照者方向转变。
  • 术前sIL-1R2与sIL-6R水平较高者术后减重更多。

核心结论

  • 减重手术可改变肥胖患者的细胞因子谱,使其向瘦对照者方向转变。
  • CCL14、sVEGFR2和PDGF-BB在肥胖中升高,CXCL12、CCL11和CCL27在肥胖中降低。

研究设计与样本

  • 横断面研究,纳入37例肥胖患者与37例瘦对照者,并追踪25例肥胖患者减重手术后变化。
  • 手术方式包括Roux-en-Y胃旁路术和袖状胃切除术。

主要发现

  • 肥胖者相对瘦对照者有13种细胞因子显著升高、4种降低。
  • sVEGFR2、sTNFR1和sTNFR2与体重及BMI正相关,sRAGE与体重及BMI负相关。
  • sTNFR2与空腹血糖、HOMA-IR及HbA1c正相关。
  • 术后脂联素升高、瘦素降低;sVEGFR2下降(P = 0.01),CXCL12上升(P = 0.03)。
  • 术前sIL-1R2和sIL-6R较高者术后减重更多(P < 0.05)。

关键数值与推荐

  • 共定量76种循环细胞因子、趋化因子及分泌型细胞因子受体。
  • 术后sVEGFR2下降P = 0.01,CXCL12上升P = 0.03。
  • 术前sIL-1R2和sIL-6R与术后减重相关P < 0.05。

临床怎么用

  • 细胞因子谱或可作为评估肥胖相关炎症及减重手术代谢获益的参考。
  • 术前sIL-1R2、sIL-6R水平可能有助于预判术后减重效果。

局限性

  • 原文摘要未报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Altered cytokine levels and chronic low-grade inflammation contribute to metabolic dysfunction in obesity. The extent of cytokine changes and their impact on metabolic improvements after bariatric surgery have not been fully explored. OBJECTIVE: To compare 76 circulating cytokines, chemokines, and secreted cytokine receptors in subjects with obesity and lean subjects and determine how these cytokines are altered by bariatric surgery. DESIGN, SETTING, AND PARTICIPANTS: A total of 37 patients with obesity and 37 lean patients in a cross-sectional study at an academic medical center. We also investigated cytokine changes in 25 patients with obesity after bariatric surgery. INTERVENTION: Bariatric surgery (Roux-en-Y gastric bypass and vertical sleeve gastrectomy). MAIN OUTCOME MEASURES: Quantification of 76 circulating cytokines, chemokines, and secreted cytokine receptors. RESULTS: A total of 13 cytokines were significantly higher, and 4 lower, in patients with obesity relative to lean controls. Soluble vascular endothelial growth factor receptor 2 (sVEGFR2), soluble TNF receptor (sTNFR) 1, and sTNFR2 were positively correlated, and soluble receptor for advanced glycation end-products was inversely correlated, with weight and body mass index. sTNFR2 was positively correlated with fasting glucose, homeostatic model assessment of insulin resistance, and hemoglobin A1c. After bariatric surgery, adiponectin increased, and leptin decreased. Elevated sVEGFR2 levels in patients with obesity were decreased (P = 0.01), whereas reduced chemokine (C-X-C motif) ligand (CXCL) 12 levels in patients with obesity increased (P = 0.03) after surgery. Patients with higher soluble interleukin receptor (sIL) 1R2 and sIL-6R levels before surgery had greater weight loss after surgery (P < 0.05). CONCLUSIONS: We demonstrate that chemokine (C-C motif) ligand (CCL) 14, sVEGFR2, and platelet-derived growth factor BB are elevated in obesity, and CXCL12, CCL11, and CCL27 are lower in obesity. We found clinically concordant directionality between lean and patients with obesity and before vs after surgery for six cytokines, suggesting that bariatric surgery shifted the cytokine profiles of patients with obesity toward that of lean controls.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Wolf RM, Jaffe AE, Steele KE, et al. Cytokine, Chemokine, and Cytokine Receptor Changes Are Associated With Metabolic Improvements After Bariatric Surgery. J Clin Endocrinol Metab. 2019. PMID: 30544212. doi:10.1210/jc.2018-02245

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。